Todd Harris
Founder bei TYRA BIOSCIENCES, INC.
Vermögen: 25 Mio $ am 31.03.2024
Profil
Todd J.
Harris is the founder of Tyra Biosciences, Inc. (founded in 2018) and Sienna Biopharmaceuticals, Inc. (founded in 2010).
He is currently the President, CEO, Treasurer & Director at Tyra Biosciences, Inc. and the Director & Head-Corporate Development at Sienna Biopharmaceuticals, Inc. Additionally, Dr. Harris is currently working as a Director at Primmune Therapeutics, Inc. since 2019.
Dr. Harris has a doctorate degree from the Massachusetts Institute of Technology, an undergraduate degree from Brigham Young University, and a graduate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
2,86% | 15.03.2024 | 1 504 577 ( 2,86% ) | 25 Mio $ | 31.03.2024 |
Aktive Positionen von Todd Harris
| Unternehmen | Position | Beginn |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Founder | 02.08.2018 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Director/Board Member | 01.10.2019 |
Ehemalige bekannte Positionen von Todd Harris
| Unternehmen | Position | Ende |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Founder | 01.07.2018 |
Ausbildung von Todd Harris
| Massachusetts Institute of Technology | Doctorate Degree |
| Brigham Young University | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
| Tyra Biosciences, Inc. |
